HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.

Abstract
Toxoplasmosis is one of the most widespread zoonoses worldwide. It has a high incidence and can result in severe disease in humans and livestock. Effective vaccines are needed to limit and prevent infection with Toxoplasma gondii. In this study, we evaluated the immuno-protective efficacy of a recombinant Toxoplasma gondii phosphoglycerate mutase 2 (rTgPGAM 2) against T. gondii infection in BALB/c mice. We report that the mice nasally immunised with rTgPGAM 2 displayed significantly higher levels of special IgG antibodies against rTgPGAM 2 (including IgG1, IgG2a and IgAs) and cytokines (including IFN-γ, IL-2 and IL-4) in their blood sera and supernatant of cultured spleen cells compared to those of control animals. In addition, an increased number of spleen lymphocytes and enhanced lymphocyte proliferative responses were observed in the rTgPGAM 2-immunised mice. After chronic infection and lethal challenge with the highly virulent T. gondii RH strain by oral gavage, the survival time of the rTgPGAM 2-immunised mice was longer (P < 0.01) and the survival rate (70%) was higher compared with the control mice (P < 0.01). The reduction rate of brain and liver tachyzoites in rTgPGAM 2-vaccinated mice reached approximately 57% and 69% compared with those of the control mice (P < 0.01). These results suggest that rTgPGAM 2 can generate protective immunity against T. gondii infection in BALB/c mice and may be a promising antigen in the further development of an effective vaccine against T. gondii infection.
AuthorsHai-Long Wang, Li-Min Wen, Yan-Jiang Pei, Fen Wang, Li-Tian Yin, Ji-Zhong Bai, Rui Guo, Chun-Fang Wang, Guo-Rong Yin
JournalParasite (Paris, France) (Parasite) Vol. 23 Pg. 12 ( 2016) ISSN: 1776-1042 [Electronic] France
PMID26984115 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© H.-L. Wang et al., published by EDP Sciences, 2016.
Chemical References
  • Cytokines
  • Immunoglobulin A, Secretory
  • Immunoglobulin G
  • Protozoan Proteins
  • Protozoan Vaccines
  • Recombinant Proteins
  • Vaccines, Synthetic
  • phosphoglycerate mutase 2, Toxoplasma gondii
  • Phosphoglycerate Mutase
Topics
  • Administration, Intranasal
  • Animals
  • Brain (parasitology)
  • Cells, Cultured
  • Cytokines (blood)
  • Drug Evaluation
  • Female
  • Immunity, Mucosal
  • Immunoglobulin A, Secretory (analysis)
  • Immunoglobulin G (blood)
  • Liver (parasitology)
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred BALB C
  • Peyer's Patches (immunology)
  • Phosphoglycerate Mutase (genetics, immunology)
  • Protozoan Proteins (genetics, immunology)
  • Protozoan Vaccines (administration & dosage, immunology)
  • Recombinant Proteins (immunology)
  • Spleen (immunology)
  • Toxoplasma (enzymology, genetics, growth & development, immunology)
  • Toxoplasmosis, Animal (blood, immunology, parasitology, prevention & control)
  • Vaccination
  • Vaccines, Synthetic (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: